Yingbin Liu

11.3k total citations
255 papers, 6.1k citations indexed

About

Yingbin Liu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yingbin Liu has authored 255 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 98 papers in Surgery and 73 papers in Oncology. Recurrent topics in Yingbin Liu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (66 papers), Cancer-related molecular mechanisms research (30 papers) and Pancreatic and Hepatic Oncology Research (29 papers). Yingbin Liu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (66 papers), Cancer-related molecular mechanisms research (30 papers) and Pancreatic and Hepatic Oncology Research (29 papers). Yingbin Liu collaborates with scholars based in China, United States and Hong Kong. Yingbin Liu's co-authors include Xiangsong Wu, Maolan Li, Yunping Hu, Jiasheng Mu, Yang Cao, Hao Weng, Yijun Shu, Wenguang Wu, Ping Dong and Runfa Bao and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Yingbin Liu

251 papers receiving 6.0k citations

Peers

Countries citing papers authored by Yingbin Liu

Since Specialization

Citations

This map shows the geographic impact of Yingbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingbin Liu more than expected).

Fields of papers citing papers by Yingbin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingbin Liu. The network helps show where Yingbin Liu may publish in the future.

Co-authorship network of co-authors of Yingbin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingbin Liu. A scholar is included among the top collaborators of Yingbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingbin Liu. Yingbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer 2025 ·Journal of Controlled Release ·(unknown), (unknown), (unknown), Mingjie Yang, Hang Xu, Yi‐Ping Li, Peihong Tong, Rong Shao, Yingbin Liu, Xianming Kong	7
2	Single-cell multi-omics in biliary tract cancers: decoding heterogeneity, microenvironment, and treatment strategies 2025 ·Molecular Biomedicine ·Nannan Tang, (unknown), (unknown), Mengyao Li, Yingbin Liu	2
3	Pancreatic cancer environment: from patient-derived models to single-cell omics 2024 ·Molecular Omics ·(unknown), Jiatong Li, Shimei Qiu, (unknown), (unknown), (unknown), Mengyao Li, Yingbin Liu	29
4	Single-cell characterization of infiltrating T cells identifies novel targets for gallbladder cancer immunotherapy 2024 ·Cancer Letters ·Yi‐Jian Zhang, (unknown), Yang Li, Liguo Liu, (unknown), Junjie Xia, (unknown), Keren Xu, Xiangsong Wu, Wei Gong, Yingbin Liu	11
5	Exploration of Dan-Shen-Yin against pancreatic cancer based on network pharmacology combined with molecular docking and experimental validation 2024 ·Current Research in Biotechnology ·(unknown), Jiatong Li, (unknown), Mengyao Li, Yingbin Liu	6
6	Advanced green synthesis: Solvent-free and catalyst-free reaction 2024 ·Green Synthesis and Catalysis ·Mengyao Li, (unknown), Jiatong Li, Yingbin Liu	10
7	Pancreatic cancer incidence and mortality trends in urban Shanghai, China from 1973 to 2017: a joinpoint regression and age-period-cohort analysis 2023 ·Frontiers in Oncology ·Mengyin Wu, Kai Gu, (unknown), Chunxiao Wu, Yi Pang, Wei Zhang, Chunfang Wang, Yan Shi, Yingbin Liu, Chen Fu	4
8	An efficient new adaptive variational mode decomposition algorithm for extracting adventitious lung sounds 2023 ·Biomedical Signal Processing and Control ·Yingbin Liu, (unknown), Shuai Yu, (unknown), (unknown), Xiaojian Han, Yuan‐Di Zhao, Shibiao Chen, Guoping Wang	4
9	Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 ·Science China Chemistry ·Mengyao Li, (unknown), (unknown), (unknown), Jiatong Li, Guo‐Qiang Lin, Yingbin Liu	17
10	EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression 2023 ·Cancer Letters ·Qiang Ma, Yijian Zhang, Haibin Liang, Fei Zhang, Fatao Liu, Shili Chen, Yunping Hu, Lin Jiang, (unknown), Maolan Li, Yingbin Liu	8
11	Pd-catalyzed intermolecular consecutive double Heck reaction “on water” under air: facile synthesis of substituted indenes 2023 ·RSC Advances ·Dong Wei, (unknown), (unknown), Chen‐Guo Feng, Guo‐Qiang Lin, Yingbin Liu	3
12	High-throughput single-cell assay for precise measurement of the intrinsic mechanical properties and shape characteristics of red blood cells 2023 ·Lab on a Chip ·(unknown), Ying Xiong, Yuhang Ma, (unknown), Yunshu Lu, (unknown), Xiaolong Wang, Huaxiong Huang, Yingbin Liu, Ming Dao, Xiaobo Gong	4
13	Edge Length-Programmed Single-Stranded RNA Origami for Predictive Innate Immune Activation and Therapy 2023 ·Journal of the American Chemical Society ·Kun Dai, Yang Xu, Yang Yang, Jianfeng Shen, Xiaoguo Liu, Xinyi Tu, (unknown), Xiaodong Qi, Jiang Li, Lihua Wang, Xiaolei Zuo, Yingbin Liu, Hao Yan, Chunhai Fan, Guangbao Yao	7
14	Solvent-free and catalyst-free direct alkylation of alkenes 2023 ·Green Chemistry ·Mengyao Li, Jiatong Li, (unknown), (unknown), (unknown), (unknown), Chen‐Guo Feng, Yingbin Liu, Guo‐Qiang Lin	5
15	Aggregation‐enabled alkene insertion into carbon–halogen bonds 2023 ·SHILAP Revista de lepidopterología ·Mengyao Li, (unknown), Xiao Han, (unknown), (unknown), Jiatong Li, Ge Zhang, (unknown), Yingbin Liu, Chunsen Li, Guo‐Qiang Lin, Chen‐Guo Feng	4
16	A redox probe screens MTHFD1 as a determinant of gemcitabine chemoresistance in cholangiocarcinoma 2021 ·Cell Death Discovery ·(unknown), Zhiqing Yuan, Yingbin Liu, Xuxu Sun, Guiyang Wang, (unknown), Junwen Qu, Jian Wang, Jie Yang, Yuzheng Zhao, Yi Yang, Kewei Li	5
17	piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis 2020 ·Nature Cell Biology ·Feng Li, Peng Yuan, (unknown), Chunhui Jin, Wei Tang, Yefei Rong, Yunping Hu, Fengjuan Zhang, Tao Wei, Qi Yin, Tingbo Liang, Ligang Wu, Jinsong Li, Dangsheng Li, Yingbin Liu, Wenhui Lou, Shuang Zhao, Mo‐Fang Liu	54
18	KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis 2016 ·Cancer Research ·Peng Yuan, (unknown), (unknown), Jing Cao, Yong Li, (unknown), Yingbin Liu, Dangsheng Li, Wenhui Lou, Mo‐Fang Liu	86
19	Role of dissection of secondary branches of splenic pedicle in portal hypertension cases undergoing splenectomy 2008 ·Chinese Medical Journal ·Yingbin Liu, Ying Kong, Xuan Wang, (unknown), Jiangtao Li, (unknown), Yan Chen, Deqing Chen, (unknown), Zhiping Zhang, Xiangsong Wu, (unknown), Zhiwei Quan, Songgang Li, Jiyu Li, Liping Cao, Shu-you Peng	5
20	[Mesenchymal stem cells inhibit the expression of CD25 on phytohaemagglutinin-activated lymphocytes]. 2007 ·PubMed ·Yingbin Liu, Haoran Qian, Defei Hong, Jianwei Wang, (unknown), Xuan Wang, (unknown), Xiaoming Ma, Yan Chen, Deqin Chen, (unknown), Shu-you Peng	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact